| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $594K | -22.3% |
| SG&A Expense | $2.0M | +30.1% |
| Operating Income | -$2.6M | -12.8% |
| Pre-tax Income | -$3.1M | -29.7% |
| Income Tax | $0 | — |
| Net Income | -$3.5M | -44.2% |
| EPS (Basic) | -$0.06 | -50.0% |
| EPS (Diluted) | -$0.06 |
| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Short-term Investments | $3.0M | -45.5% |
| Current Assets | $5.0M | -20.8% |
| Total Assets | $5.0M | -34.3% |
| Current Liabilities | $322K | +11.9% |
| Total Liabilities | $322K | +11.9% |
| Stockholders' Equity | $4.7M | -36.1% |
| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.7M | +16.5% |
| Capital Expenditures | $2K | — |
| Investing Cash Flow | $2.5M | +145.4% |
| Free Cash Flow | -$1.7M | +16.4% |